Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AC Immune SA - Common Stock
(NQ:
ACIU
)
3.410
-0.270 (-7.34%)
Streaming Delayed Price
Updated: 3:00 PM EST, Jan 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AC Immune SA - Common Stock
< Previous
1
2
3
4
5
Next >
Unusual volume stocks in Friday's session
↗
December 12, 2025
Unusual volume stocks are being observed in Friday's session.
Via
Chartmill
Why Is AC Immune Stock Up Over 23% Today?
↗
December 11, 2025
ACIU shares surged over 23% after the company announced positive results from an interim Phase 2 study.
Via
Stocktwits
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease
December 11, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune to Present at the Jefferies 2025 London Healthcare Conference
November 11, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 04, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board
October 28, 2025
From
AC Immune SA
Via
GlobeNewswire
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
October 24, 2025
From
AC Immune SA
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 03, 2025
Via
Benzinga
Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine
September 25, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
September 04, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
August 05, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
April 30, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
April 02, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
March 25, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
March 13, 2025
From
AC Immune SA
Via
GlobeNewswire
AC Immune to Participate in Upcoming Investor Conferences
March 04, 2025
From
AC Immune SA
Via
GlobeNewswire
Eliminating Some Screened Stocks
↗
February 09, 2025
Commodity prices regularly swing 25-30% or more in any given year. When this happens, the financial health of these firms can get dicey very quickly, given the amount of capital investment it requires...
Via
Talk Markets
Topics
Stocks / Equities
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
December 10, 2024
From
AC Immune SA
Via
GlobeNewswire
S&P 500 Moves Lower; US Crude Oil Inventories Increase
↗
November 14, 2024
Via
Benzinga
Topics
Stocks
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
↗
November 14, 2024
AC Immune reports interim results from Phase 2 trial of ACI-7104.056 active immunotherapy for early Parkinson's disease.
Via
Benzinga
Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday
↗
November 14, 2024
Via
Benzinga
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
November 14, 2024
From
AC Immune SA
Via
GlobeNewswire
AC Immune to Present at the Jefferies 2024 London Healthcare Conference
November 13, 2024
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
November 05, 2024
From
AC Immune SA
Via
GlobeNewswire
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
↗
September 23, 2024
Via
Benzinga
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
September 17, 2024
From
AC Immune SA
Via
GlobeNewswire
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
August 28, 2024
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
August 06, 2024
From
AC Immune SA
Via
GlobeNewswire
AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024
July 31, 2024
From
AC Immune SA
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
